Search Results - "Barot, Shimoli Vipul"

Clinical and Molecular Heterogeneity of Moderate Aplastic Anemia by Patel, Bhumika J., Barot, Shimoli Vipul, Kuzmanovic, Teodora, Przychodzen, Bartlomiej P., Hirsch, Cassandra M., Awada, Hassan, Hasipek, Metis, Thota, Swapna, Radivoyevitch, Tomas, Advani, Anjali S., Kalaycio, Matt, Sekeres, Mikkael A., Carraway, Hetty E., Maciejewski, Jaroslaw P.

“…Based on clinical Camitta criteria, acquired aplastic anemia is categorized according to the degree of blood count depression as severe (sAA) or moderate…”
Get full text

TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of Cancer by Colombari Figueroa, Sophia, Patel, Bhumika J., Barot, Shimoli Vipul, Kuzmanovic, Teodora, Nazha, Aziz, Hsi, Eric D., Cook, James R., Mukherjee, Sudipto, Gerds, Aaron T., Sekeres, Mikkael A., Kalaycio, Matt, Advani, Anjali S., Maciejewski, Jaroslaw P., Carraway, Hetty E.

“…▪ Background: Next generation sequencing (NGS) of bone marrow or peripheral blood is increasingly being used in the upfront evaluation of patients with a new…”
Get full text

Impact of Eltrombopag on Clonal Evolution in Refractory Aplastic Anemia by Patel, Bhumika J., Barot, Shimoli Vipul, Przychodzen, Bartlomiej P., Kuzmanovic, Teodora, Clemente, Michael, Hirsch, Cassandra M., Visconte, Valeria, Souaid, Roy, Versalle, Marissa, Lee, Sarah S, Radivoyevitch, Tomas, Haspiek, Metis, Thota, Swapna, Nazha, Aziz, Kalaycio, Matt, Advani, Anjali S., Carraway, Hetty E., Sekeres, Mikkael A., Maciejewski, Jaroslaw P.

“…▪ Despite documented success of IST in tx of aplastic anemia (AA), a significant minority of pts remain refractory to tx and most clinical responses are…”
Get full text

Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2mutations after Intensive Chemotherapy by Thota, Swapna, Patel, Bhumika J., Carraway, Hetty E., Griffiths, Elizabeth A., Przespolewski, Amanda, Thompson, James E., Kuzmanovic, Teodora, Nazha, Aziz, Barot, Shimoli Vipul, Hirsch, Cassandra M., Przychodzen, Bartlomiej P., Mukherjee, Sudipto, Scully, Meghan, Gerds, Aaron T., Advani, Anjali S., Sekeres, Mikkael A., Meggendorfer, Manja, Wang, Eunice S., Maciejewski, Jaroslaw P.

“…Background: AML and MDS are heterogeneous myeloid neoplasias (MN) characterized by varied pathogenic mechanisms and associated with mixed clinical outcome…”
Get full text